Mr Ramon K Domingo, MD | |
2500 S. Hwy 305, Mccamey, TX 79752 | |
(432) 652-4010 | |
(432) 652-4013 |
Full Name | Mr Ramon K Domingo |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 2500 S. Hwy 305, Mccamey, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083610265 | NPI | - | NPPES |
83953F | Other | TX | BCBS PROVIDER # |
E7892 | Other | TX | LICENSE NUMBER |
122439 | Other | TX | SUPERIOR PCP # |
82Y568 | Other | TX | BCBS PROVIDER # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | E7892 (Texas) | Primary |
207R00000X | Internal Medicine | E7892 (Texas) | Primary |
207RG0100X | Internal Medicine - Gastroenterology | E7892 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Ramon K Domingo, MD Po Box 1200, Mc Camey, TX 79752-1200 Ph: (432) 652-4010 | Mr Ramon K Domingo, MD 2500 S. Hwy 305, Mccamey, TX 79752 Ph: (432) 652-4010 |
News Archive
Rep. Tom Perriello, D-Va., spent Wednesday touting the new health reform law as he campaigns to win re-election, unlike other Democrats. Perriello's visit occurred the same day that President Barack Obama appeared in Northern Virginia in an attempt to regain some momentum for the health reforms, which have been a top issue in mid-term congressional races across the country.
President Obama is moving quickly to head off opposition to major health care legislation from fiscal conservatives in Congress by vowing to follow strict rules for paying for it without further driving up the already huge deficit.
A new study finds that - even in a field with clear standards and online databases - the rate of public data archiving in cancer research is increasing only slowly. Furthermore, research studies in cancer and human subjects are less likely than other research studies to make their datasets available for reuse.
Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide.
› Verified 7 days ago